drugset / Trial / NCT04610801

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

NCT04610801

RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to assess the efficacy of Xylitol plus Grapefruit Seed Extract (Xlear) nasal spray as an adjunct treatment of COVID-19.

Timeline

Start
2021-12-08
Primary completion
2022-06-08
Completion
2022-08-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Grapefruit Seed Extract Unknown 2 unknown Intranasal
Subject Xylitol Small molecule 2 unknown Intranasal

Indications